Lygos
YC W16San Francisco, US · 55 employees · 5 known investors
Lygos uses genetically engineered microorganisms to produce industrial chemicals from sugar feedstocks, focusing on compounds where fermentation offers cost advantages compared to fossil fuel-based manufacturing.
Founders & leadership· Y Combinator alumni (W16)
Eric SteeninFounder/CSO
Investors · 5
In the news
- Lygos and Ginkgo Bioworks Announce Partnership to Optimize Production of Biobased Specialty Chemicals - Lygoslygos.com · 2022
- Cannabis Researchers Seek to Unlock the Healing Power of Pot - WSJwsj.com · 2021
- Lygos takes in $15.5 mln Series Bventurecapitaljournal.com · 2018